RMTI can be bullish and only confirmed if breaks out the symmetrical triangle. otherwise it cancels the whole forecast. 2.10 and 4.11 are resistants of a previous support. 10 is the wave target.
Weekly downtrend Wedge breakout + pull back Possible double bottom RSI Divergence Entry 0.96 Stop 0.7 Target 3.5 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.
Buy: $1.0 to $1.10 Target-1 - $1.60 Target-2 - $2.20 Target-3 - $3.50 SL: $0.83 ROXADUSTAT PRESENTS A NEW OPPORTUNITY FOR TRIFERIC New anemia drug expected to transform treatment & change iron requirements for dialysis patients Roxadustat is a new approach to treatment of the anemia of CKD •A physiologic approach to anemia mgmt. with improved safety vs. ESA’s* •...
Rockwell Medical - Possible wedge breakout. Retest 1.86 / 2.05-new support levels PT Range 2.47-2.57 Rockwell Medical, is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L....
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
touch the resistance and have the potential to rise.
We see a repeating pattern here, will it repeat again? a series of HHs and LLs, Solid trendline with multiple touches. Risk of failure: Bear Market I will most likely enter this trade on the next trading day after the open. Too good to resist, with a good r/r and a tight stop!
With our great trading RMTI I will be having their FDA approval decision on March 28th but why do we care well already I had a previous history of those spikability but it's also running up in price . we have both positive and positive directional and some high-volume leading up to this approval that so I'm going to be violently starting this opportunity for some...
Rockwell Medical, Inc. engages in targeting end-stage renal disease and chronic kidney disease. Its dialysis products include hemodialysis concentrates, citrapure, dri-sate, safety data sheets,ancillary products, and renal pure. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
We saw about a $.18 or 4% gain today. I am only guessing here. But RSI is climbing and the green candle has almost no tail I may need some help desiphering the details but would hope to get at lest another 4%.
RMTI is currently at the bottom of it's trendline since plummeting to $3.50 per share back in November. Stock is great to trade when the trend is sideways. Hoping for triferic and calcitroil news for earnings, but I don't have my hopes up.